Clinical Trial Update: Long Term Open Follow-up With H376/95 vs. Warfarin [Phase 2]

View source ↗

Summary

Phase 2 long-term open-follow-up comparing H376/95 to Warfarin for stroke prevention in patients with atrial fibrillation. The study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Drugs mentioned

• H376/95
• Warfarin (warfarin)

Snippet

Sponsor: AstraZeneca | Conditions: Stroke Prevention in Patients With Atrial Fibrillation | Phase 2 | Status: TERMINATED